LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ortho Clinical Diagnostics Presents Cardiac Advances at EuroMedLab 2019

By LabMedica International staff writers
Posted on 20 May 2019
Print article
Image: The Multi-Test VITROS chemistry product slides (Photo courtesy of Ortho Clinical Diagnostics).
Image: The Multi-Test VITROS chemistry product slides (Photo courtesy of Ortho Clinical Diagnostics).
Ortho Clinical Diagnostics (Raritan, NJ, USA) sponsored an educational workshop on high-sensitivity troponin assays and presented five scientific posters at EuroMedLab 2019, the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place from May 19-23, 2019, at the CCIB - Centre Convencions Internacional in Barcelona. Ortho also displayed its new multi-test VITROS Chemistry Product Slides, the VITROS Cell, a compact automation solution allowing two VITROS XT 7600 instruments (launched in 2018) to operate as a seamless solution, and the VITROS XT 7600 Integrated System at its booth during the congress.

Ortho, an in vitro diagnostics company serving the clinical laboratory and immunohematology communities, offers sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories.

In addition to the educational workshop, "The Clinical Use and Performance of High-Sensitivity Troponin Assays with the Esc 0-1 Algorithm: Overcoming Challenges in Implementation," Ortho presented the following five scientific posters at EuroMedLab:

- Evaluation of the New Multi-Test VITROS Chemistry Product Slides on the VITROS XT 7600 Integrated System
- Sigma Metrics for Assessing the Analytical Quality of the New Multi-Test VITROS XT Chemistry Products Slides
- Precision of the New Multi-Test VITROS Chemistry Product Slides on the VITROS XT 7600 Integrated System
- Performance Evaluation of the VITROS hs Troponin I Assay on the VITROS ECi/ECiQ and 3600 Immunodiagnostic and VITROS 5600/XT 7600 Integrated Systems
- Performance Evaluation of the VITROS Immunodiagnostic Products B·R·A·H·M·S PCT Assay on the VITROS 3600 Immunodiagnostic System

"Ortho is committed to staying ahead of the rapidly evolving clinical lab environment," said Joan Martin, executive vice president and head of Ortho's EMEA region." At this year's EuroMedLab, we're proud to be presenting data on two of our just-launched, key product offerings: our new high-sensitivity troponin assay and Ortho's VITROS XT MicroSlide. The XT MicroSlide can perform two tests simultaneously to improve lab workflow performance, productivity and clinical outcomes."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more